Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Myriad Genetics (MYGN)
NASDAQ:MYGN
Myriad Genetics (MYGN) Stock Price & Analysis
333 Followers
MYGN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$13.92 - $24.21
Previous Close$16.04
Volume1.14M
Average Volume (3M)512.27K
Market Cap
$1.31B
Enterprise Value$1.40B
Total Cash (Recent Filing)$121.60M
Total Debt (Recent Filing)$203.80M
Price to Earnings (P/E)-5.3
Beta1.65
Next Earnings
Oct 31, 2023EPS Estimate
-$0.08Last Dividend Ex-Date
Jun 15, 2009Dividend YieldN/A
Share Statistics
EPS (TTM)-3.05
Shares Outstanding81,883,426
10 Day Avg. Volume663,623
30 Day Avg. Volume512,268
Standard Deviation0.17
R-Squared0.34
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)14.72
Price to Sales (P/S)7.16
Price to Cash Flow (P/CF)-19.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.00
Enterprise Value/Gross Profit2.93
Enterprise Value/Ebitda-7.16
Forecast
1Y Price Target
$24.00Price Target Upside49.63% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering3
Myriad Genetics News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MYGN FAQ
What was Myriad Genetics’s price range in the past 12 months?
Myriad Genetics lowest stock price was $13.92 and its highest was $24.21 in the past 12 months.
What is Myriad Genetics’s market cap?
Currently, no data Available
When is Myriad Genetics’s upcoming earnings report date?
Myriad Genetics’s upcoming earnings report date is Oct 31, 2023 which is in 29 days.
How were Myriad Genetics’s earnings last quarter?
Myriad Genetics released its earnings results on Aug 03, 2023. The company reported -$0.08 earnings per share for the quarter, beating the consensus estimate of -$0.081 by $0.001.
Is Myriad Genetics overvalued?
According to Wall Street analysts Myriad Genetics’s price is currently Undervalued.
Does Myriad Genetics pay dividends?
Myriad Genetics pays a Notavailable dividend of $1.75 which represents an annual dividend yield of N/A. See more information on Myriad Genetics dividends here
What is Myriad Genetics’s EPS estimate?
Myriad Genetics’s EPS estimate is -$0.08.
How many shares outstanding does Myriad Genetics have?
Myriad Genetics has 81,883,420 shares outstanding.
What happened to Myriad Genetics’s price movement after its last earnings report?
Myriad Genetics reported an EPS of -$0.08 in its last earnings report, beating expectations of -$0.081. Following the earnings report the stock price went down -6.985%.
Which hedge fund is a major shareholder of Myriad Genetics?
Among the largest hedge funds holding Myriad Genetics’s share is Glenview Capital Management LLC. It holds Myriad Genetics’s shares valued at 87M.
---
Myriad Genetics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$24.00 (49.63% Upside)
$24.00 (49.63% Upside)
Blogger Sentiment
Bullish
MYGN Sentiment 66%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 462.9K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-17.78%
12-Months-Change
Fundamentals
Return on Equity
-29.50%
Trailing 12-Months
Asset Growth
-1.90%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Myriad Genetics
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic test. It operates through the Diagnostics and Other segments. The Diagnostics segment provides testing and collaborative development of testing that is designed to asses an individual's risk of developing a disease later in life. The Other segment offers products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients; and also includes corporate services such as finance, human resources, legal, and information technology. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.
---
Top 5 ETFs holding MYGN
Vanguard Total Stock Market ETF
$43.06M
Vanguard Russell 3000 ETF
$89.82K
SPDR S&P 1500 Value Tilt ETF
$9.37K
V-Shares US Leadership Diversity ETF
$67.16
Invesco S&P US Total Market ESG Tilt Index ETF Trust Units -CAD Hedged-
$45.32
Up to five ETFs with an Outperform Smart Score that hold MYGN. The ETFs are listed according to market value of MYGN within the ETF
---